Novartis said its anti-inflammatory drug Cosentyx eased the symptoms of a painful, lump-forming skin condition in two late-stage trials, putting the approved treatment on track to further shore up sales growth at the Swiss drugmaker.
New York Governor Kathy Hochul declared a disaster emergency on Friday in a bid to accelerate efforts to vaccinate residents against polio after the virus was detected in wastewater samples taken in four counties.
Biogen announced that its mid-stage monoclonal antibody, litifilimab, is showing promise in reducing joint pain related to systemic lupus erythematosus (SLE) lupus.
Moderna is preparing for multiple product launches over the next several years, including RSV and flu vaccines and boosters for COVID-19. It is also aiming mRNA programs at rare diseases.
Sanofi and Regeneron Pharmaceuticals presented results Friday from the Phase III PRIME trial that showed Dupixent (dupilumab) strongly improves itching and skin lesions in adult patients with prurigo nodularis.
North Korean leader Kim Jong Un has suggested that the isolated country could begin COVID-19 vaccinations in November, state media reported on Friday.
The U.S. Food and Drug Administration has received several reports of certain types of cancers in the scar tissue that forms around breast implants, the agency said in a safety notice on Thursday.
The U.S. Food and Drug Administration on Thursday alerted healthcare providers about a potential clip lock issue with Abbott Laboratories’ MitraClip device used to stop heart valve leakage.
The United States will boost its stockpile of at-home COVID-19 tests, ordering more than 100 million tests from domestic manufacturers, the White House said on Thursday, but warned it was a short-term solution.
Thousands of FDA employees may lose their jobs if Congress doesn’t reappropriate funding currently in place by the end of the month, according to a report by Bloomberg Law.
